SCYNEXIS Inc (SCYX) income statement
SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3072% below fair value
$2.82−0.03 (-1.05%)
Close on Nov 18, 2026Market cap $28.06MP/E –Yield –
SCYNEXIS Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -117.6%
- Net margin
- -53.3%
- Return on equity, FY2025
- -16.5%
Financial strength
- Current ratio
- 9.65
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 180.0%
Valuation
- P/E ratio
- –
- Price to sales
- 1.46
- Price to book
- 0.42
- Dividend yield
- –
See a number that looks wrong?